Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus.
MacIntosh Grant CornwellElliot S Luttrell-WilliamsMichael GolpanianHanane El BannoudiKhrystyna MyndzarPeter IzmirlyH Michael BelmontStuart KatzNathaniel R SmilowitzAlexis EngelRobert ClancyKelly RugglesJill P BuyonJeffrey S BergerPublished in: Lupus science & medicine (2021)
HCQ use was associated with decreased platelet activation and activation-related transcripts and improved vascular health in SLE.